***Background.*** Antiseptics such as chlorhexidine have been utilized to decrease the incidence of healthcare associated infections. A number of genes in *S. aureus*, notably *qacA/B* and *smr*, have been associated with tolerance to antiseptics. Work at our institution has revealed the emergence of *S. aureus* possessing these genes among pediatric cancer and cardiac surgery patients. We examined the prevalence of antiseptic tolerant *S. aureus* among all nosocomial isolates at our institution as well as provided molecular and clinical characterization of these organisms.

***Methods.*** Isolates were obtained from an ongoing prospective *S. aureus* surveillance study; isolates obtained after more than 72 hours of hospitalization during the years 2007-2013 were identified. Antimicrobial susceptibility was determined by the clinical microbiology lab in the routine course of clinical care. All isolates underwent PCR for the antiseptic tolerance genes *qacA/B* and *smr*; isolates positive by PCR were further characterized by PFGE.

***Results.*** 280 isolates were included in the study of which 114 (40.7%) were methicillin-resistant (MRSA). The median age of patients was 3.3 months (IQR: 0.9-73.2). Ninety isolates (32.1%) were positive for *smr* while 61 (21.4%) were positive for *qacA/B*; 28 isolates (10%) carried both genes. The proportion of isolates positive for these genes varied from year-to-year but was lowest in 2007 (\<5%) and was highest for *smr* in 2009 (92%) and for *qacA/B* (87.2%) in 2013. *smr* positive isolates were more often MRSA (53.3% vs 34.7%, p 0.004), clindamycin resistant (33.3% vs 24.7%, p 0.08) and associated with invasive infections (78.9% vs 64.7%, p 0.01). *qacA/B* positive isolates were more often associated with the diagnosis of bacteremia specifically (50.8% vs 35.6% p 0.03). The most common PFGE type among antiseptic tolerant isolates was USA300 (20%); numerous other pulsotypes accounted for the remainder of isolates.

***Conclusion.*** *S. aureus* possessing antiseptic tolerant genes are common among nosocomial isolates at our institution. These isolates are more often associated with a multidrug resistant phenotype and more severe infections. These trends should be monitored in light of the continued use of antiseptics both in the hospital and community settings.
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